U.S. Next-generation Sequencing Services Market (2024 - 2030) Size, Share & Trends Analysis Report By Service Type, By Workflow (Pre-sequencing, Sequencing, Data Analysis), By End-use, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Service Type
                       1.2.2. Workflow
                       1.2.3. End-use
                       1.2.4. Estimates and forecasts timeline
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                       1.4.5. Details of primary research
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity flow analysis (Model 1)
                       1.7.2. Approach 1: Commodity flow approach
                       1.7.3. Volume price analysis (Model 2)
                       1.7.4. Approach 2: Volume price analysis
                   1.8. List of Secondary Sources
                   1.9. List of Primary Sources
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Snapshot
                   2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Next-generation Sequencing Services Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market driver analysis
                       3.2.2. Market restraint analysis
                       3.2.3. Market opportunity analysis
                   3.3. U.S. Next-generation Sequencing Services Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s
                       3.3.2. PESTEL Analysis
Chapter 4. U.S. Next-generation Sequencing Services Market: Service Type Estimates & Trend Analysis
                   4.1. U.S. Next-generation Sequencing Services Market: Service Type Dashboard
                   4.2. U.S. Next-generation Sequencing Services Market: Service Type Movement Analysis
                   4.3. U.S. Next-generation Sequencing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030
                   4.4. Human Genome Sequencing Services
                       4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   4.5. Single Cell Sequencing Services
                       4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   4.6. Microbial Genome-based Sequencing Services
                       4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   4.7. Gene Regulation Services
                       4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.7.2. ChIP Sequencing Service
                           4.7.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.7.3. Small RNA Sequencing Service
                           4.7.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.7.4. Other Gene Regulation-based Service
                           4.7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   4.8. Animal & Plant Sequencing Services
                       4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   4.9. Other Sequencing Services
                       4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Next-generation Sequencing Services Market: Workflow Estimates & Trend Analysis
                   5.1. U.S. Next-generation Sequencing Services Market: Workflow Dashboard
                   5.2. U.S. Next-generation Sequencing Services Market: Workflow Movement Analysis
                   5.3. U.S. Next-generation Sequencing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030
                   5.4. Pre-sequencing Services
                       5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   5.5. Sequencing Services
                       5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   5.6. Data Analysis Services
                       5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Next-generation Sequencing Services Market: End-use Estimates & Trend Analysis
                   6.1. U.S. Next-generation Sequencing Services Market: End-use Dashboard
                   6.2. U.S. Next-generation Sequencing Services Market: End-use Movement Analysis
                   6.3. U.S. Next-generation Sequencing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030
                   6.4. Universities & Other Research Entities
                       6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   6.5. Hospitals & Clinics
                       6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   6.6. Pharma & Biotech Entities
                       6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   6.7. Other End-uses
                       6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
                   7.1. Recent Developments & Impact Analysis, By Key Market Participants
                   7.2. Company/Competition Categorization
                   7.3. Key company market share/position analysis, 2023
                   7.4. Vendor Landscape
                       7.4.1. Illumina, Inc.
                           7.4.1.1. Company overview
                           7.4.1.2. Financial performance
                           7.4.1.3. Product benchmarking
                           7.4.1.4. Strategic initiatives
                       7.4.2. Thermo Fisher Scientific Inc.
                           7.4.2.1. Company overview
                           7.4.2.2. Financial performance
                           7.4.2.3. Product benchmarking
                           7.4.2.4. Strategic initiatives
                       7.4.3. Eurofins Scientific SE
                           7.4.3.1. Company overview
                           7.4.3.2. Financial performance
                           7.4.3.3. Product benchmarking
                           7.4.3.4. Strategic initiatives
                       7.4.4. PerkinElmer, Inc.
                           7.4.4.1. Company overview
                           7.4.4.2. Financial performance
                           7.4.4.3. Product benchmarking
                           7.4.4.4. Strategic initiatives
                       7.4.5. QIAGEN
                           7.4.5.1. Company overview
                           7.4.5.2. Financial performance
                           7.4.5.3. Product benchmarking
                           7.4.5.4. Strategic initiatives
                       7.4.6. Quest Diagnostics Incorporated
                           7.4.6.1. Company overview
                           7.4.6.2. Financial performance
                           7.4.6.3. Product benchmarking
                           7.4.6.4. Strategic initiatives
                       7.4.7. Azenta Life Sciences (GENEWIZ)
                           7.4.7.1. Company overview
                           7.4.7.2. Financial performance
                           7.4.7.3. Product benchmarking
                           7.4.7.4. Strategic initiatives
                       7.4.8. NanoString
                           7.4.8.1. Company overview
                           7.4.8.2. Financial performance
                           7.4.8.3. Product benchmarking
                           7.4.8.4. Strategic initiatives
                       7.4.9. PacBio
                           7.4.9.1. Company overview
                           7.4.9.2. Financial performance
                           7.4.9.3. Product benchmarking
                           7.4.9.4. Strategic initiatives
                       7.4.10. bioMérieux
                           7.4.10.1. Company overview
                           7.4.10.2. Financial performance
                           7.4.10.3. Product benchmarking
                           7.4.10.4. Strategic initiatives
                       7.4.11. BGI Group
                           7.4.11.1. Company overview
                           7.4.11.2. Financial performance
                           7.4.11.3. Product benchmarking
                           7.4.11.4. Strategic initiatives
                       7.4.12. F. Hoffmann-La Roche Ltd
                           7.4.12.1. Company overview
                           7.4.12.2. Financial performance
                           7.4.12.3. Product benchmarking
                           7.4.12.4. Strategic initiatives
                       7.4.13. ARUP Laboratories
                           7.4.13.1. Company overview
                           7.4.13.2. Financial performance
                           7.4.13.3. Product benchmarking
                           7.4.13.4. Strategic initiatives
                       7.4.14. Novogene Co, Ltd.
                           7.4.14.1. Company overview
                           7.4.14.2. Financial performance
                           7.4.14.3. Product benchmarking
                           7.4.14.4. Strategic initiatives
                       7.4.15. Gene by Gene Ltd.
                           7.4.15.1. Company overview
                           7.4.15.2. Financial performance
                           7.4.15.3. Product benchmarking
                           7.4.15.4. Strategic initiatives
                       7.4.16. Lucigen Corporation
                           7.4.16.1. Company overview
                           7.4.16.2. Financial performance
                           7.4.16.3. Product benchmarking
                           7.4.16.4. Strategic initiatives

List of Tables

Table 1. List of abbreviation
Table 2. U.S. next-generation sequencing services market, 2018 - 2030 (USD Million)
Table 3. U.S. next-generation sequencing services market, by service type, 2018 - 2030 (USD Million)
Table 4. U.S. next-generation sequencing services market, by workflow, 2018 - 2030 (USD Million)
Table 5. U.S. next-generation sequencing services market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 U.S. next-generation sequencing services market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Product and stage segment snapshot
Fig. 11 Sales channel segment snapshot
Fig. 12 Market dynamics
Fig. 13 Porter’s five forces analysis
Fig. 14 PESTLE analysis
Fig. 15 U.S. next-generation sequencing services market: Service type outlook and key takeaways
Fig. 16 U.S. next-generation sequencing services market: Service type movement analysis
Fig. 17 Human genome sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Single cell sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Microbial genome-based sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Gene regulation services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Animal & plant sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Other sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 U.S. next-generation sequencing services market: Workflow outlook and key takeaways
Fig. 24 U.S. next-generation sequencing services market: Workflow movement analysis
Fig. 25 Pre-sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Data analysis services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 U.S. next-generation sequencing services market: End-use outlook and key takeaways
Fig. 29 U.S. next-generation sequencing services market: End-use movement analysis
Fig. 30 Universities & other research entities market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Hospitals & clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Pharma & biotech entities market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Other end-uses market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Company market share analysis, 2023
Fig. 35 Strategic framework